Back to Article List

FTC contests support over brain health advertising claims


Jan 26, 2022

The Federal Trade Commission (FTC) pushed back against arguments made by Quincy Bioscience that its advertising claims for Prevagen—a brain health supplement—are supported by “competent and reliable scientific evidence.”

According to the complaint, the defendants represented in national TV ads and elsewhere that Prevagen improves memory within 90 days, reduces memory problems associated with aging, and provides other cognitive benefits, like healthy brain function, a sharper mind, and clearer thinking. What’s more, they claimed to have clinical proof to support their advertising promises.


For further information (in English), click on the Link

Related Articles
See All News
Subscribe to our newsletter

The best industry insight in your mailbox